Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Other Operating Expenses (2024 - 2025)

Carlsmed (CARL) has disclosed Other Operating Expenses for 2 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to $4.9 million, compared with a TTM value of $25.3 million through Dec 2025, changed N/A, and an annual FY2025 reading of $35.0 million, up 63.13% over the prior year.
  • Other Operating Expenses was $4.9 million for Q4 2025 at Carlsmed, down from $20.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $20.4 million in Q3 2025 and bottomed at $4.9 million in Q4 2025.